Associated Partner

University of Manchester

Manchester,

United Kingdom

The University of Manchester in the United Kingdom is a powerhouse of research and is ranked among the leading research universities globally. In this project, the University of Manchester will be involved in WP 1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Key People Involved:

Matthew Krebs

MD, PhD, Chief Investigator DETERMINE, University of Manchester

Kate Duffus

PhD, Research Project Manager in Experimental Cancer Medicine, University of Manchester

Louise Carter

MD, PhD, Co-Investigator DETERMINE, University of Manchester

Natalie Cook

MD, PhD, Co-Investigator DETERMINE, University of Manchester

partners

Beneficiaries & Associated Partners

Associated Partner

Center for Personalized Cancer Treatment hosted by Radboud University Medical Center

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Associated Partner

Region Skåne

Participation in WP1 (data aggregation) and WP3 (expansion cohorts).

Associated Partner

National Institute of Oncology (NIO)

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).